Recent investigations reported efficacy of UBS109, EF31 and Bisacurone against pancreatic cancer growth and breast cancer metastasis which majorly act upon NFκB and inhibit this cascade by suppressing IKKα and β69–71. Here, NFKB1 is linked to pancreatic neoplasm.